Greenwich LifeSciences reported cash from operations of -$4.70M and free cash flow of -$4.70M for the quarter ended Mar 2026, down 156.3% year over year. This cash flow statement covers 26 quarters of results from Dec 2019 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -0.75M | -0.86M | -2.36M | -1.97M | -0.75M | -2.32M | -2.79M | -2.12M | -1.63M | -2.39M | -2.75M | -2.47M | -2.61M | -2.67M | -9.67M | -2.74M | -4.03M | -4.15M | -7.92M | -5.66M | ||||||
| Share-based Compensation | 0.17M | 0.17M | 0.17M | 0.17M | 0.22M | 0.76M | 0.59M | 0.59M | 0.59M | 0.59M | 0.59M | 0.59M | 0.59M | 0.59M | 5.47M | 1.54M | 1.54M | 1.54M | 2.17M | 1.54M | ||||||
| Cash from Operations | -0.60M | -0.89M | -2.26M | -1.95M | -0.53M | -1.55M | -2.17M | -1.56M | -0.97M | -1.80M | -2.15M | -1.78M | -1.05M | -2.58M | -1.85M | -1.83M | -2.23M | -2.67M | -3.17M | -4.70M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Amortizatization of Intangibles | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 903.00 | 876.00 | |||||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in Account Payables | -0.33M | -0.07M | -0.07M | 0.03M | 0.09M | 0.99M | -0.56M | 2.03M | -0.64M | 0.76M | -0.19M | 2.14M | -0.37M | |||||||||||||
| Change in Accured Expenses | 0.02M | 0.06M | 0.01M | -0.14M | -0.01M | 0.01M | 0.03M | -0.03M | -0.01M | 0.07M | -0.03M | 0.00M | -0.03M | 0.05M | 0.28M | 0.01M | -0.00M | 0.12M | 0.24M | -0.22M | ||||||
| Financing Activities | ||||||||||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||
| Long-Term Debt Repayments | 5.51M | 2.02M | ||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Equity Issued and Repurchased | 0.56M | 0.30M | 2.20M | 0.49M | 2.61M | 3.21M | 5.55M | 9.03M | ||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||
| Cash from Financing Activities | 0.56M | -5.51M | -2.02M | 0.30M | 2.77M | 1.18M | 0.12M | 0.49M | 2.61M | 3.35M | 5.55M | 9.03M | ||||||||||||||
| Change in Cash | -0.60M | -0.89M | -1.70M | -7.46M | -2.56M | -1.55M | -2.17M | -1.56M | -0.97M | -1.80M | -2.15M | -1.48M | 1.72M | -1.40M | -1.73M | -1.34M | 0.38M | 0.68M | 2.37M | 4.33M | ||||||
| Free Cash Flow | -0.60M | -0.89M | -2.26M | -1.95M | -0.53M | -1.55M | -2.17M | -1.56M | -0.97M | -1.80M | -2.15M | -1.78M | -1.05M | -2.58M | -1.85M | -1.83M | -2.23M | -2.67M | -3.17M | -4.70M | ||||||
| Net Cash Flow | -0.60M | -0.89M | -1.70M | -7.46M | -2.56M | -1.55M | -2.17M | -1.56M | -0.97M | -1.80M | -2.15M | -1.48M | 1.72M | -1.40M | -1.73M | -1.34M | 0.38M | 0.68M | 2.37M | 4.33M |
Pull Greenwich LifeSciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=GLSI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "GLSI", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=GLSI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();